Welcome, Sign In
Januvia Weighs Down Merck's Sales
Description:Merck reported disappointing first-quarter sales weighed down by a slowdown of its Januvia diabetes drug and cut its profit forecast for the full year.
januvia earnings previews
merk earnings reports
stock market commentary